This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Evotec Appoints Ingrid Müller COO
Business executive appointment

Evotec Appoints Ingrid Müller COO

Analysis based on 7 articles · First reported Apr 15, 2026 · Last updated Apr 15, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of a new Chief Operating Officer, Ingrid Müller, at Evotec is likely to be viewed positively by the market, as her extensive experience is expected to enhance Evotec's operational efficiency and growth strategy. This could lead to a slight positive sentiment for Evotec's stock.

biotechnology pharmaceuticals
Event Summary

Evotec announced the appointment of Dr. Ingrid Müller as its new Chief Operating Officer (COO), effective May 1, 2026. Dr. Müller brings over 20 years of international leadership experience from the life sciences industry, having previously held senior roles at CureVac, Sanofi, and Fresenius — Fresenius (company). In her new role, she will oversee Evotec's global operations and the implementation of its Horizon initiative, focusing on quality, productivity, scalability, delivery, and cost. Christian Wojczewski, CEO of Evotec, expressed confidence that Dr. Müller's expertise will be crucial for the company's ongoing growth transformation and strategic execution.

Entities Involved
stock
Evotec
Evotec appointed Dr. Ingrid Müller as its Chief Operating Officer, which is expected to strengthen its global operations and growth transformation.
Importance 100.0 Sentiment 20.0
per
Ingrid Müller
Ingrid Müller was appointed Chief Operating Officer of Evotec, bringing over 20 years of international leadership experience to oversee global operations and the Horizon initiative.
Importance 90.0 Sentiment 20.0
per
Christian Wojczewski
Christian Wojczewski, CEO of Evotec, welcomed Ingrid Müller to the company, highlighting her strategic perspective and operational discipline.
Importance 30.0 Sentiment 10.0
stock
CureVac
Ingrid Müller previously served as Vice President Portfolio Strategy & Execution at CureVac.
Importance 10.0 Sentiment 0.0
subs
Fresenius — Fresenius (company)
Ingrid Müller held senior international leadership roles at Fresenius — Fresenius (company) prior to joining Evotec.
Importance 10.0 Sentiment 0.0
stock
Sanofi
Ingrid Müller held senior international leadership roles at Sanofi prior to joining Evotec.
Importance 10.0 Sentiment 0.0
Relationships
Evotec related ↔ Christian Wojczewski
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.